4//SEC Filing
MAZELSKY JONATHAN JAY 4
Accession 0000874716-25-000134
CIK 0000874716other
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 5:00 PM ET
Size
7.0 KB
Accession
0000874716-25-000134
Insider Transaction Report
Form 4
MAZELSKY JONATHAN JAY
Executive Vice President
Transactions
- Exercise/Conversion
Common Stock
2025-08-08$598.49/sh+183$109,523→ 83,494.302 total - Exercise/Conversion
Premium Incentive Stock Option (right-to-buy)
2025-08-08−183→ 0 totalExercise: $598.49Exp: 2031-02-13→ Common Stock (183 underlying)
Footnotes (2)
- [F1]Grant of option at a 110% premium to the closing price of Issuer common stock on the Nasdaq Global Select Market on February 12, 2021 to buy shares of Issuer common stock that became exercisable in one installment on February 14, 2025.
- [F2]Not applicable.
Documents
Issuer
IDEXX LABORATORIES INC /DE
CIK 0000874716
Entity typeother
Related Parties
1- filerCIK 0001556270
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 5:00 PM ET
- Size
- 7.0 KB